Vanda Pharmaceuticals (VNDA) Other Working Capital Changes (2010 - 2026)

Vanda Pharmaceuticals has disclosed Other Working Capital Changes across 17 years of filings, most recently posting $5.8 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $5.8 million, up 7.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.4 million (down 11.02% YoY), and the FY2025 annual result was $12.1 million, up 77.04% from the prior year.
• Other Working Capital Changes came in at $5.8 million for Q1 2026 at Vanda Pharmaceuticals, down from $5.9 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $13.4 million in Q1 2022 to a low of -$11.3 million in Q1 2023.
• The 5-year median for Other Working Capital Changes is $1.4 million (2025), against an average of $1.3 million.
• Peak annual rise in Other Working Capital Changes reached 26820.0% in 2022, while the deepest fall reached 398.11% in 2022.
• Vanda Pharmaceuticals' Other Working Capital Changes stood at -$3.4 million in 2022, then plunged by 108.59% to -$7.2 million in 2023, then soared by 150.58% to $3.6 million in 2024, then surged by 63.43% to $5.9 million in 2025, then retreated by 2.96% to $5.8 million in 2026.
• The last three Other Working Capital Changes figures came in at $5.8 million (Q1 2026), $5.9 million (Q4 2025), and -$703000.0 (Q3 2025), per Business Quant data.